Vor Biopharma's total assets for Q4 2024 were $142.89M, an increase of 23.19% from the previous quarter. VOR total liabilities were $46.23M for the fiscal quarter, a 7.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.